535
Views
14
CrossRef citations to date
0
Altmetric
Clinical Trial Report

Menopausal Symptoms and Associated Social and Environmental Factors in Midlife Chinese Women

, ORCID Icon, , &
Pages 2195-2208 | Published online: 16 Nov 2020

References

  • Jehan S, Masters-Isarilov A, Salifu I, et al. Sleep disorders in postmenopausal women. J Sleep Disord Ther. 2015;4:1000212.26512337
  • Al-Safi ZA, Santoro N. Menopausal hormone therapy and menopausal symptoms. Fertil Steril. 2014;101:905–915.24613533
  • Monteleone P, Mascagni G, Giannini A, et al. Symptoms of menopause – global prevalence, physiology and implications. Nat Rev Endocrinol. 2018;14:199–215.29393299
  • Nelson HD. Menopause. Lancet. 2008;371:760–770.18313505
  • Moilanen J, Aalto AM, Hemminki E, et al. Prevalence of menopause symptoms and their association with lifestyle among Finnish middle-aged women. Maturitas. 2010;67:368–374.20869181
  • Santoro N, Epperson CN, Mathews SB. Menopausal symptoms and their management. Endocrin Metab Clin. 2015;44:497–515.
  • Harlow SD, Gass M, Hall JE, et al. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. Menopause. 2012;19:387–395.22343510
  • Portman DJ, Gass MLS. Vulvovaginal Atrophy Terminology Consensus Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women’s Sexual Health and The North American Menopause Society. J Sex Med. 2014;11:2865–2872.25155380
  • Cohen L, Soares C, Vitonis A, et al. Risk for new onset of depression during the menopausal transition. Arch Gen Psychiat. 2006;63:385–390.16585467
  • Heinemann K, Ruebig A, Potthoff P, et al. The Menopause Rating Scale (MRS) scale: a methodological review. Health Qual Life Out. 2004;2:45.
  • Schoenaker DAJM, Jackson CA, Rowlands JV, et al. Socioeconomic position, lifestyle factors and age at natural menopause: a systematic review and meta-analyses of studies across six continents. Int J Epidemiol. 2014;43(5):1542–1562. doi:10.1093/ije/dyu09424771324
  • Gava G, Orsili I, Alvisi S, et al. Cognition, mood and sleep in menopausal transition: the role of menopause hormone therapy. Medicina. 2019;55:668.
  • Woods NF, Mitchell ES. Symptoms during the perimenopause: prevalence, severity, trajectory, and significance in women’s lives. Menopause. 2005;118:0–24.
  • Bromberger JT, Kravitz HM, Youk A, et al. Patterns of depressive disorders across 13 years and their determinants among midlife women: SWAN mental health study. J Affect Disorder. 2016;206:31–40. doi:10.1016/j.jad.2016.07.005
  • Woods NF, Mariella A, Mitchell ES. Depressed mood symptoms during the menopausal transition: observations from the Seattle Midlife Women’s Health Study. Climacteric. 2008;15:223‐232.
  • Freeman EW, Sammel MD, Boorman DW, et al. Longitudinal pattern of depressive symptoms around natural menopause. JAMA Psychiatry. 2014;71(1):36–43. doi:10.1001/jamapsychiatry.2013.281924227182
  • Ruan X, Cui Y, Du J, et al. Prevalence of climacteric symptoms comparing perimenopausal and postmenopausal Chinese women. J Psychosom Obstgyn. 2017;38(3):161–169. doi:10.1080/0167482X.2016.1244181
  • Greendale GA, Huang M, Wight RG, et al. Effects of the menopause transition and hormone use on cognitive performance in midlife women. Neurology. 2009;72:1850.19470968
  • Kravitz HM, Ganz PA, Bromberger J, et al. Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition. Menopause. 2003;10:19.12544673
  • Politi M, Schleinitz M, Col N. Revisiting the duration of vasomotor symptoms of menopause: a meta-analysis. J Gen Intern Med. 2008;23:1507–1513.18521690
  • Freeman E, Sammel M, Lin H, et al. Duration of menopausal hot flushes and associated risk factors. Obstet Gynecol. 2011;117:1095–1104.21508748
  • Avis NE. Change in sexual functioning over the menopausal transition: results from the study of women’s health across the nation. Menopause. 2017;4:379–390.
  • Cagnacci AVMXASA. Female sexuality and vaginal health across the menopausal age. Am J Med. 2020;1:14–19.
  • De Zambotti M, Trinder J, Colrain IM, et al. Menstrual cycle-related variation in autonomic nervous system functioning in women in the early menopausal transition with and without insomnia disorder. Psychoneuroendocrino. 2016;75:44–51.
  • Thayer JF, Yamamoto SS, Brosschot JF. The relationship of autonomic imbalance, heart rate variability and cardiovascular disease risk factors. Int J Cardiol. 2010;141:131.
  • Saleh TM, Connell BJ. Role of oestrogen in the central regulation of autonomic function. Clin Exp Pharmacol P. 2007;34:827–832.
  • Laboratory FR. Ambulatory monitoring of menopausal hot flashes. Psychophysiology. 2010;26:573–579.
  • Dhanoya T, Sievert LL, Muttukrishna S, et al. Hot flushes and reproductive hormone levels during the menopausal transition. Maturitas. 2016;89:43–51.27180159
  • Meng W, Gong WW, Hu RY, et al. Age at natural menopause and associated factors in adult women: findings from the China Kadoorie Biobank study in Zhejiang rural area. PLoS One. 2018;13:e195658.
  • Caretto M, Giannini A, Simoncini T. An integrated approach to diagnosing and managing sleep disorders in menopausal women. Maturitas. 2019;128:1–3.31561815
  • Nascimento CMPJDA. Physical exercise in MCI elderly promotes reduction of pro-inflammatory cytokines and improvements on cognition and BDNF peripheral levels. Curr Alzheimer Res. 2014;11:799–805.25212919
  • Weuve J, Kang JH, Manson JE, et al. Physical activity, including walking, and cognitive function in older women. JAMA. 2004;292:1454–1461.15383516
  • Hoffmann K, Sobol NA, Frederiksen KS, et al. Moderate-to-high intensity physical exercise in patients with Alzheimer’s disease: a randomized controlled trial. J Alzheimers Dis. 2016;50:443–453.26682695
  • Miller BF, Olesen JL, Hansen M, et al. Coordinated collagen and muscle protein synthesis in human patella tendon and quadriceps muscle after exercise. J Physiol. 2005;567:1021–1033.16002437
  • Stuenkel CADSGA. Treatment of symptoms of the menopause: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2015;100:3975–4011.26444994
  • Baber RJ PNFA, Group. IW. 2016 IMS Recommendations on women’s midlife health and menopause hormone therapy. Climacteric. 2016;19:109–150.26872610
  • Schmidt M, Arjomand-Wölkart K, Birkhäuser MH, et al. Consensus: soy isoflavones as a first-line approach to the treatment of menopausal vasomotor complaints. Gynecol Endocrinol. 2016;32:427–430.26943176
  • Ruan X, Mueck AO, Beer AM, et al. Benefit–risk profile of black cohosh (isopropanolic Cimicifuga racemosa extract) with and without St.John’s wort in breast cancer patients. Climacteric. 2019;22:339–347.30626212
  • Gold EB, Block G, Crawford S, et al. Lifestyle and demographic factors in relation to vasomotor symptoms: baseline results from the study of women’s health across the nation. Am J Epidemiol. 2004;159:1189–1199.15191936
  • Freeman EW, Sammel MD, Grisso JA, et al. Hot flashes in the late reproductive years: risk factors for African American and Caucasian women. J Women Health Gend Based Med. 2001;10:67–76.